Physican-scientists are the lifeblood of health/medical research but training is challenging.
We've published on challenges/supports for those enrolled in a PhD.
A formal mentoring scheme was popular.
Australian Academy of Health and Medical Sciences Monash University School of Clinical Sciences Monash Medicine, Nursing and Health Sciences Monash Health
onlinelibrary.wiley.com/doi/10.1111/im…

Thanks Benjamin - look forward to seeing you and the FVSG team and colleagues in Melbourne with @ANSVASC and my co-convenors Catherine Hill and Vicki Quincey !

Andreas Kronbichler Kitching Laboratory Thanks - definitely save the date!
The Workshop will be hosted by ANZ Vasculitis Society ANZVASC the society - and the co-convenors are Catherine Hill @vickiquincey and Kitching Laboratory

It's been a wonderful 21st International Vasculitis Workshop in Barcelona Vasculitis Workshop Barcelona #VasculitisBCN2024
And the big news: in 2026 - the 22nd Workshop will be hosted by ANZ Vasculitis Society in Melbourne!
We are excited and will do everything we can to host a great interactive workshop. See you in 2026!

Excellent work from nephrologist and PhD student Dr Huan Dang. Human MPO-ANCA can be pathogenic in vivo. Vasculitis Workshop Barcelona #VasculitisBCN2024

Ron Falk, a giant in the field of #vasculitis and nephrology from UNC Kidney Center, giving the Fokko van der Woude opening plenary lecture at Vasculitis Workshop Barcelona #VasculitisBCN2024

It's a nice figure - drawn originally by co-authot david jayne !

Safak Mirioglu Silke R Brix JASN_News Hans-Joachim Anders Martin Windpessl And then we are moving to the supplement of our article. This is a Figure also re-drawn from a wonderful review by Kitching Laboratory, Hans-Joachim Anders et al. (nature.com/articles/s4157…)

Great to be involved, thank you for inviting me - Peter Merkel doing all the hard work...
the Patient/Community conference is so important and is now an integral part of the workshop.

We are delighted to present a NEW SERIES of Reviews on #vasculitis thelancet.com/series/vasculi…
Free to read with reg on lancet.com until May 1st Artwork by Chiara Vercesi #VasculitisBCN2024

New review in The Lancet Rheumatology - MPO-specific ANCA-associated vasculitis. sciencedirect.com/science/articl…
It was great to be able to work with such talented colleagues on this paper - one of a series - just prior to Vasculitis Workshop Barcelona #VasculitisBCN2024
Free access to May 21 2024: authors.elsevier.com/c/1isC99UBHvrr…

Thanks Australian Academy of Health and Medical Sciences for this excellent symposium.
Honoured to have the chance to speak. Tricky and somewhat 'meta' - a talk on how to do a talk....

Welcome to our Life as a Clinician-Scientist Victoria event. We’ll be live tweeting today as we hear from the state’s top health and medical minds. Tag us to join the conversation

Reliable prediction tools are needed to personalize treatment in ANCA-associated GN. This study shows the updated ANCA kidney risk score optimizes clinicopathologic prognostication for clinical practice and trials bit.ly/JASN0274

The 21st Vasculitis Workshop Vasculitis Workshop Barcelona #VasculitisBCN2024 chaired by the eminent and energetic Maria Cid - a record 500 abstracts!
Lots of Australians and New Zealanders going. ANZ 🍷🍺🥛+ tapas Sat night. All welcome!
NOTE - early bird registration discount ends Jan 15 - register now!

Excited to announce the WEHI board has appointed Professor Ken Smith as our next director. 👏👏👏

We look forward to welcoming Ken when he commences in the role in May 2024.

Read the story 👇
wehi.edu.au/news/new-direc…

Actually from an excellent paper first authored by Marta Casal Moura and now formally published in NDT

AAV in special populations session. A/Prof Vincent Lee summarises the (sparse) literature re AAV in pregnancy.

Dr Jen Lee presents on transplantation considerations in AAV. Transplant > 12 months from remission.

Managing AAV while on dialysis. Dr Bhadran Bose presents data indicating a low risk of relapse ~6/100 pt years (related to dialysis immunosuppression?) and little benefit of continuing treatment beyond 4 months from dialysis start.